SunOpta Inc. (NASDAQ:STKL – Get Free Report) (TSE:SOY) saw a large drop in short interest during the month of April. As of April 15th, there was short interest totalling 5,950,000 shares, a drop of 23.0% from the March 31st total of 7,730,000 shares. Based on an average daily volume of 826,300 shares, the short-interest ratio is currently 7.2 days.
SunOpta Trading Down 1.5 %
NASDAQ STKL traded down $0.10 during trading on Tuesday, reaching $6.55. 479,843 shares of the stock traded hands, compared to its average volume of 809,579. The firm has a market cap of $775.06 million, a price-to-earnings ratio of -4.28 and a beta of 1.73. The stock’s 50-day moving average price is $6.51 and its 200 day moving average price is $5.60. The company has a quick ratio of 0.65, a current ratio of 1.19 and a debt-to-equity ratio of 1.48. SunOpta has a fifty-two week low of $2.79 and a fifty-two week high of $8.51.
SunOpta (NASDAQ:STKL – Get Free Report) (TSE:SOY) last issued its quarterly earnings data on Wednesday, February 28th. The company reported $0.05 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.01 by $0.04. The firm had revenue of $181.62 million during the quarter, compared to analysts’ expectations of $165.10 million. SunOpta had a negative net margin of 22.85% and a positive return on equity of 4.05%. Analysts predict that SunOpta will post 0.14 EPS for the current year.
Insiders Place Their Bets
Institutional Inflows and Outflows
Institutional investors have recently bought and sold shares of the stock. Signaturefd LLC lifted its stake in SunOpta by 67.4% in the third quarter. Signaturefd LLC now owns 7,663 shares of the company’s stock valued at $26,000 after buying an additional 3,085 shares in the last quarter. PNC Financial Services Group Inc. lifted its position in shares of SunOpta by 50.9% in the third quarter. PNC Financial Services Group Inc. now owns 10,189 shares of the company’s stock worth $34,000 after purchasing an additional 3,439 shares in the last quarter. Evergreen Capital Management LLC bought a new stake in shares of SunOpta in the third quarter worth $37,000. Regal Investment Advisors LLC bought a new stake in shares of SunOpta in the third quarter worth $42,000. Finally, NBC Securities Inc. bought a new stake in shares of SunOpta in the fourth quarter worth $65,000. Institutional investors own 85.39% of the company’s stock.
Analysts Set New Price Targets
A number of equities analysts have recently commented on the stock. BMO Capital Markets raised their price objective on shares of SunOpta from $9.00 to $10.00 and gave the stock an “outperform” rating in a report on Thursday, February 29th. DA Davidson raised their price objective on shares of SunOpta from $8.00 to $9.00 and gave the stock a “buy” rating in a report on Tuesday, March 5th. Finally, Canaccord Genuity Group raised their price objective on shares of SunOpta from $8.00 to $9.00 and gave the stock a “buy” rating in a report on Thursday, February 29th. One investment analyst has rated the stock with a sell rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, SunOpta presently has a consensus rating of “Moderate Buy” and a consensus price target of $9.40.
Get Our Latest Stock Report on SunOpta
SunOpta Company Profile
SunOpta Inc engages in manufacture and sale of plant-based and fruit-based food and beverage products in the United States, Canada, and internationally. The company provides plant-based beverages utilizing oat, almond, soy, coconut, rice, hemp, and other bases under the Dream and West Life brands; oat-based creamers under the SOWN brand; ready-to-drink protein shakes; and nut, grain, seed, and legume based beverages; packaged teas and concentrates; and meat and vegetable broths and stocks.
Further Reading
- Five stocks we like better than SunOpta
- Buy P&G Now, Before It Sets A New All-Time High
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- Health Care Stocks Explained: Why You Might Want to Invest
- Hilton Demonstrates Asset Light is Right for Investors
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for SunOpta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SunOpta and related companies with MarketBeat.com's FREE daily email newsletter.